Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide

Product NDC
57664-797
Requested package NDC
57664-797-99
11-digit product format
576640797
Labeler code
57664
Product ID
57664-797_e97e6623-9454-4d2f-8cbc-d84db5f0b5ce
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
olmesartan medoxomil, amlodipine besylate and hydrochlorothiazide
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Sun Pharmaceutical Industries, Inc.
Application
NDA200175
Marketing category
NDA AUTHORIZED GENERIC
Marketing start
2016-10-26
Marketing end
2024-04-30
Substance
AMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMIL
Active strength
5 mg/1; mg/1; mg/1
Pharmacologic classes
Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
NDC exclude flag
No
Listing certified through
0000-00-00
Current FDA listing
Historical FDA.report record

NDC auxiliary status#

Explicit status records from FDA unfinished, excluded, and compounder auxiliary files. Absence of a row is not itself a regulatory status. Browse every current auxiliary row, including rows without a usable NDC. · Browse every captured source and parsed snapshot.

Current NDC status page 1 of 1 · 1 matching rows.

Dataset, Scope, Product NDC table
DatasetScopeProduct NDCPackage NDCCodeStatusReporting periodSource date
excluded packagepackage57664-79757664-797-99DDiscontinued by firm2026-07-31

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 5 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
N200175-001TRIBENZORAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILEQ 5MG BASE;12.5MG;20MGTABLET / ORALABRLD2010-07-23
N200175-002TRIBENZORAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILEQ 5MG BASE;12.5MG;40MGTABLET / ORALABRLD2010-07-23
N200175-003TRIBENZORAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILEQ 5MG BASE;25MG;40MGTABLET / ORALABRLD2010-07-23
N200175-004TRIBENZORAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILEQ 10MG BASE;12.5MG;40MGTABLET / ORALABRLD2010-07-23
N200175-005TRIBENZORAMLODIPINE BESYLATE; HYDROCHLOROTHIAZIDE; OLMESARTAN MEDOXOMILEQ 10MG BASE;25MG;40MGTABLET / ORALABRLD, RS2010-07-23

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 5 matching rows.

Application-product, TE code table
Application-productTE code
N200175-001AB
N200175-002AB
N200175-003AB
N200175-004AB
N200175-005AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-08-01 22:54:322026-06N200175-001TRIBENZOREQ 5MG BASE;12.5MG;20MGTABLET / ORALABRLD2010-07-23a50c72e98297…
2026-08-01 22:54:322026-06N200175-002TRIBENZOREQ 5MG BASE;12.5MG;40MGTABLET / ORALABRLD2010-07-23a50c72e98297…
2026-08-01 22:54:322026-06N200175-003TRIBENZOREQ 5MG BASE;25MG;40MGTABLET / ORALABRLD2010-07-23a50c72e98297…
2026-08-01 22:54:322026-06N200175-004TRIBENZOREQ 10MG BASE;12.5MG;40MGTABLET / ORALABRLD2010-07-23a50c72e98297…
2026-08-01 22:54:322026-06N200175-005TRIBENZOREQ 10MG BASE;25MG;40MGTABLET / ORALABRLD, RS2010-07-23a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-08-01 22:54:322026-06N200175-001AB1a50c72e98297…
2026-08-01 22:54:322026-06N200175-002AB1a50c72e98297…
2026-08-01 22:54:322026-06N200175-003AB1a50c72e98297…
2026-08-01 22:54:322026-06N200175-004AB1a50c72e98297…
2026-08-01 22:54:322026-06N200175-005AB1a50c72e98297…

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TribenzorOLMESARTAN MEDOXOMIL / AMLODIPINE BESYLATE / HYDROCHLOROTHIAZIDECosette Pharmaceuticals, Inc.2f56d0bc-236b-41a0-9fc0-21cdfea8d8902023-07-12Boxed warning, Warnings, Adverse reactionsExact identifier
application applno (NDA): 200175
application number: NDA200175

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
57664-797-83EA - Each57664-797d92df01f-846b-44df-a9a0-b7844522957b12016-11-08
57664-797-99EA - Each57664-797e8c21c34-ff43-49df-a3ab-644dc15f4e1112016-11-08

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
57664-797-995766407979990 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (57664-797-99) 2016-10-262024-04-30NoNoCurrent